191 related articles for article (PubMed ID: 30999829)
1. Incidence and risk factors for invasive pneumococcal disease in HIV-positive individuals in the era of highly active antiretroviral therapy.
Sadlier C; O'Connell S; Kelleher M; Bergin C
Int J STD AIDS; 2019 Apr; 30(5):472-478. PubMed ID: 30999829
[TBL] [Abstract][Full Text] [Related]
2. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
[TBL] [Abstract][Full Text] [Related]
4. The persisting burden of invasive pneumococcal disease in HIV patients: an observational cohort study.
Siemieniuk RA; Gregson DB; Gill MJ
BMC Infect Dis; 2011 Nov; 11():314. PubMed ID: 22078162
[TBL] [Abstract][Full Text] [Related]
5. The impact of antiretroviral treatment on the burden of invasive pneumococcal disease in South African children: a time series analysis.
Nunes MC; von Gottberg A; de Gouveia L; Cohen C; Moore DP; Klugman KP; Madhi SA
AIDS; 2011 Feb; 25(4):453-62. PubMed ID: 21178754
[TBL] [Abstract][Full Text] [Related]
6. Trends in mortality and antibiotic resistance among HIV-infected patients with invasive pneumococcal disease.
Grau I; Ardanuy C; Liñares J; Podzamczer D; Schulze MH; Pallares R
HIV Med; 2009 Sep; 10(8):488-95. PubMed ID: 19459987
[TBL] [Abstract][Full Text] [Related]
7. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
[TBL] [Abstract][Full Text] [Related]
8. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
9. Invasive pneumococcal disease in HIV-infected adults: clinical changes after the introduction of the pneumococcal conjugate vaccine in children.
Burgos J; Peñaranda M; Payeras A; Villoslada A; Curran A; Garau M; Riera M; Crespo M; Navarro J; Van den Eynde E; Planes AM; Ribera E; Pahissa A; Falcó V
J Acquir Immune Defic Syndr; 2012 Jan; 59(1):31-8. PubMed ID: 22156821
[TBL] [Abstract][Full Text] [Related]
10. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System.
Marcus JL; Baxter R; Leyden WA; Muthulingam D; Yee A; Horberg MA; Klein DB; Towner WJ; Chao CR; Quesenberry CP; Silverberg MJ
AIDS Patient Care STDS; 2016 Oct; 30(10):463-470. PubMed ID: 27749111
[TBL] [Abstract][Full Text] [Related]
11. Invasive pneumococcal disease among HIV-positive individuals, 2000-2009.
Yin Z; Rice BD; Waight P; Miller E; George R; Brown AE; Smith RD; Slack M; Delpech VC
AIDS; 2012 Jan; 26(1):87-94. PubMed ID: 22008657
[TBL] [Abstract][Full Text] [Related]
12. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
Barry PM; Zetola N; Keruly JC; Moore RD; Gebo KA; Lucas GM
AIDS; 2006 Feb; 20(3):437-44. PubMed ID: 16439878
[TBL] [Abstract][Full Text] [Related]
13. Invasive pneumococcal disease (IPD) in HIV infected patients in Israel since the introduction of pneumococcal conjugated vaccines (PCV): Analysis of a nationwide surveillance study, 2009-2014.
Chowers M; Regev-Yochay G; Mor O; Cohen-Poradosu R; Riesenberg K; Zimhony O; Chemtob D; Stein M; Dagan R; Levy I
Hum Vaccin Immunother; 2017 Jan; 13(1):216-219. PubMed ID: 27648488
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal vaccination in people living with HIV.
Thornhill J; Sivaramakrishnan A; Orkin C
Vaccine; 2015 Jun; 33(28):3159-60. PubMed ID: 25128803
[TBL] [Abstract][Full Text] [Related]
15. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
16. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program.
Nunes MC; von Gottberg A; de Gouveia L; Cohen C; Kuwanda L; Karstaedt AS; Klugman KP; Madhi SA
PLoS One; 2011; 6(11):e27929. PubMed ID: 22140487
[TBL] [Abstract][Full Text] [Related]
17. Imputing the Direct and Indirect Effectiveness of Childhood Pneumococcal Conjugate Vaccine Against Invasive Pneumococcal Disease by Surveying Temporal Changes in Nasopharyngeal Pneumococcal Colonization.
Nzenze SA; Madhi SA; Shiri T; Klugman KP; de Gouveia L; Moore DP; Karstaedt AS; Tempia S; Nunes MC; von Gottberg A
Am J Epidemiol; 2017 Aug; 186(4):435-444. PubMed ID: 28482004
[TBL] [Abstract][Full Text] [Related]
18. Incidence and Risk Factors for Invasive Pneumococcal Disease and Community-acquired Pneumonia in Human Immunodeficiency Virus-Infected Individuals in a High-income Setting.
Garcia Garrido HM; Mak AMR; Wit FWNM; Wong GWM; Knol MJ; Vollaard A; Tanck MWT; Van Der Ende A; Grobusch MP; Goorhuis A
Clin Infect Dis; 2020 Jun; 71(1):41-50. PubMed ID: 31634398
[TBL] [Abstract][Full Text] [Related]
19. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
[TBL] [Abstract][Full Text] [Related]
20. Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis.
van Aalst M; Lötsch F; Spijker R; van der Meer JTM; Langendam MW; Goorhuis A; Grobusch MP; de Bree GJ
Travel Med Infect Dis; 2018; 24():89-100. PubMed ID: 29860151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
